Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)

Similar documents
Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (COM) COURSE DESCRIPTION

SOPs for FDA-Regulated Industry Best Practices to Withstand FDA Expectations

Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)

Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries)

PV (Pharmacovigilance) Audit Strategy Planning - A Practical Approach to Design and Implementation

Computer System Validation - Reduce Costs and Avoid 483s

Packaging and Labeling in Pharmaceutical Production

21 CFR Part 11 Compliance for SaaS/Cloud Applications

Reduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR

Effectively Addressing and Remediating FDA's Form 483 Findings, Warning Letters and Consent Decree Compliance Issues

Investigational New Drug (IND) & Investigational Device Exemptions (IDE) Applications Preparation and Submission, and Conducting FDA Meetings

SOPs for FDA-Regulated Industry: Best Practices to Withstand FDA Expectations

Applying ISO14971 / IEC62304 / IEC A Practical Guide On How To Implement Risk Management

Statistical Analysis for Process and Product Development

PV (Pharmacovigilance) Audit Strategy Planning - A Practical Approach to Design and Implementation

Biocompatibility Testing for Medical Devices

Biocompatibility Testing for Medical Devices

Managing Your FDA Inspection: Before, During and After

FDA's New Import Program for Strict Precision

Designing and Sustaining New and Existing Product Stability Testing Program

Managing Your Complaints and Obstacles in Post-Market Requirements -- Results from Top Medical Device Observations During an Inspection

Investigational New Drug (IND) & Investigational Device Exemptions (IDE) Applications Preparation and Submission, and Conducting FDA Meetings

Maintenance Reserves Seminar 2019

Technical Aspects of a Leased Asset 2019

International Trade Finance

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit

Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical Devices

Root Cause Analysis and CAPA using 8-D Problem Solving Method

International Trade Finance

Statistical Process and Quality Control

CA HR HR Generalists and CA Supervisors Too

Expense Reporting Best Practices

Sciences, South Carolina College of Pharmacy, MUSC Campus, Charleston, SC.

Project Management for Human Resources

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Pulmonary We provide answers: The most current ICD-10 and CPT coding instruction ICD-10-CM examples for your specialty Strategies to assist correct co

Most Cardiology seminars are sponsored by the State Chapters of the ACC.

Most Cardiology seminars are sponsored by the State Chapters of the ACC.

Most Cardiology seminars are sponsored by the State Chapters of the ACC.

Gastroenterology We provide answers: The most current ICD-10 and CPT coding instruction ICD-10-CM examples for your specialty Strategies to assist cor

Residency Program Coordinator Boot Camp

Medicare Boot Camp Rural Health Clinic Version

Medicare Boot Camp Rural Health Clinic Version

Medicare Boot Camp Rural Health Clinic Version

1st IRF Regional Conference & Exhibition for Road Safety The Road to Zero

Account Payable Best Practices

IRF Global R2T Conference & Exhibition. Building the Transport Infrastructure of Tomorrow

Risk Based Incoming Quality Assurance (IQA)

Safety Culture 2019 (BLR)

2019 Revenue Integrity Symposium

HR World 2019 *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY!

Certified Chief Information Security Officer (CCISO)

Evaluation and Management Boot Camp Professional Version

Colorado: Leader As Coach: Leadership Development Master Class

Medicare Boot Camp Provider-Based Departments Version

Most Peripheral Cardiology seminars are sponsored by the State Chapters of the ACC.

REACH and RoHS Compliance: Gain a Deeper Understanding

Skilled Nursing Facility Billing Boot Camp

Skilled Nursing Facility Billing Boot Camp

Skilled Nursing Facility Billing Boot Camp

ACDIS Symposium: Outpatient CDI Conference

Medicare Boot Camp Long-Term Care Version

Medicare Boot Camp Long-Term Care Version

Medicare Boot Camp Long-Term Care Version

Stability Studies for Pharmaceutical Products (API and finished products)

Texas: Leader As Coach: Leadership Development Master Class

Companies are realizing the value of. cost-effective option. an opinion regarding a business company performance.

Tennessee: Leader As Coach: Leadership Development Master Class (BLR)

Process Validation for FDA Regulated Industries

Certified Network Defender (CND)

Bring this workshop to your location: For more information, contact PharmaEd Resources at (217) PharmaED

The FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics

National Conference on Student Leadership

GxP Auditing, Remediation, and Quality System Resourcing

NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program COMPUTERIZED SYSTEM VALIDATION

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

Risk Adjustment Documentation and Coding Boot Camp

Risk Adjustment Documentation and Coding Boot Camp

Risk Adjustment Documentation and Coding Boot Camp

FDA Scrutiny of Promotion and Advertising Practices

Participants of this seminar who pass the optional exam will be eligible for IRF's New Procurement & Contract Professional (Details Coming Soon!

Medicare Boot Camp Audits, Appeals, and Denials Version

Medicare Boot Camp Utilization Review Version

Understanding GxP (GMP, GCP & GLP) for FDA Regulated Industries

Process Validation. Instructor Philip K. Ngai, Ph.D.* Senior Advisor & Trainer. National University of Singapore Academy of GxP Excellence (NUSAGE)

2 Day Seminar. Supplier Management for Medical Device Manufacturers 12 RAPS CREDITS. Jun Boston

Shanghai Event Program Change Table Sessions Creative Spark

Barcelona Event Program Change Table Sessions Creative Spark

Medicare Boot Camp Critical Access Hospital Version

Medicare Boot Camp Critical Access Hospital Version

Medicare Boot Camp Critical Access Hospital Version

GxP Auditing, Remediation, and Staff Augmentation

Survival Kit for Regulatory Inspections

EFFECTIVE PROCESS VALIDATION NUSAGE PharmEng Pharmaceutical and Biotechnology Training Program Copyright 2014 NUSAGE-PharmEng.

NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program FUNDAMENTALS OF MEDICAL DEVICE REGULATORY AFFAIRS

2 Day Seminar Assuring Data Integrity in the Life Science industry. Manufacturers

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

Effective Risk Management in Aircraft Leasing and Aviation Finance 2019

a n d B i o s a fety C o n s i d e ra t i o n s

Transcription:

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs) *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! The globalization of the pharmaceutical supply chain has led increased use of Contract Manufacturing Organizations (CMOs). The use of CMOs provides many benefits; however, it can present unique compliance risks, particularly since the operations are not in your facility and therefore not under your direct control. The compliance risks are highlighted by FDA Warning Letter trends, the majority of which are related to serious compliance and data integrity issues at foreign CMO sites. If you use CMOs, your company has the ultimate responsibility for product quality, safety, efficacy, and cgmp compliance. Furthermore, FDA has clearly stated that organizations using CMOs will be held accountable for CMO compliance to cgmps, as well as adherence to regulatory commitments. Therefore, issues identified at your CMO may result in FDA 483s and/or Warning Letters issued to your company. Since FDA is holding firms using CMOs responsible, it is imperative that your organization have a robust CMO management system. At the end of the day, your organization s ability to provide proper quality oversight of CMOs is the key to assuring product safety and your company s compliance profile. This seminar will help all personnel responsible for CMO oversight understand how to manage CMOs- from start to finish. In-depth focus will be placed on Selection and Qualification, Quality Agreements, Understanding of CMO Operations, and Review of Key CMO Records. Considerations for different types of manufacturing will be highlighted, and techniques for managing difficult CMO situations will be discussed. This is a practical how-to course, designed to provide participants with skills they can immediately apply to CMO oversight within their own organizations. Group exercises will allow participants to practice skill sets with feedback from the instructor. Seminar Fee Includes: Lunch AM-PM Tea/Coffee Seminar Material USB with seminar presentation Hard copy of presentation Attendance Certificate $100 Gift Cert for next seminar Learning Objectives: Upon completing this course, participants should be able to: Understand the CMO business model Learn the regulatory requirements for CMO quality oversight Learn how to structure your organization for effective CMO oversight Learn key points for selecting and qualifying CMOs Learn how to prepare for and conduct CMO Qualification Audits Learn how to develop a Quality Agreement and how to execute it Learn how to understand CMO operations Learn key points for reviewing CMO records Learn how to resolve issues identified in CMO records

Learn how to prepare for and conduct routine CMO audits Learn how to manage CMOs on an ongoing basis Who will Benefit: This course is designed for people tasked with oversight of these CMO functions: Manufacturing operations Quality Control operations Quality Assurance operations The following personnel will benefit from the course: Pharmaceutical Development Quality Control Validation Regulatory Affairs Quality Assurance Project Management AGENDA Day 01(8:00 AM - 4:30 PM) Registration Process: 8:30 AM 9:00 AM Session Start Time: 9:00 AM The CMO Business Model What is CMO Oversight? Regulatory Requirements for CMO Oversight FDA Expectations and Warning Letters Structuring Your Organization for CMO Oversight Manufacturing Chemistry / Laboratory Quality Assurance Regulatory Affairs Project Management Group Exercise # 1- Structuring Your Organization CMO Selection and Qualification Key Selection / Qualification Criteria Overall Considerations Considerations for API CMOs Considerations for Drug Product CMOs Considerations for Aseptic Manufacturing CMOs Considerations for Testing Laboratory CMOs Evaluating CMOs vs. Selection / Qualification Criteria Group Exercise # 2- CMO Selection and Qualification CMO Qualification Audits Overall Considerations for CMO Qualification Audits CMO Questionnaires Risk Assessments for Use of Questionnaires Evaluation of Questionnaire Responses Audit Planning Auditor Selection Determining Audit Purpose / Scope Audit Agenda Audit Execution Introductory Meeting / Orientation

Area Tours Document Review / Interviews Time Management Audit Findings Group Exercise # 3- Audit Agenda The Quality Agreement Regulatory Requirements Elements of the Quality Agreement Negotiating the Quality Agreement Executing the Quality Agreement Group Exercise # 4- Quality Agreement Day 02(8:00 AM - 4:30 PM) Getting to Know Your CMO Understanding CMO Operations Operational/Communication Style How to Deal with the Seven CMO Personality Types Review of Key CMO Records Batch Records Change Controls Group Exercise # 5- Change Control Critique Deviation Investigations / CAPA Group Exercise # 6- Deviation Investigation Critique OOS Investigations Group Exercise # 7- OOS Investigation Critique Hot Topic- Data Integrity Routine CMO Audits Audit Planning Audit Execution Differences from CMO Qualification Audits Ongoing CMO Oversight Overall Considerations Elements of Effective Ongoing CMO Oversight SPEAKER Andrew Campbell Pharmaceutical Consultant - Quality & Compliance Andrew Campbell has 25 years of pharmaceutical quality assurance and quality systems experience in both industry and consulting roles. Mr. Campbell has worked in clinical supply and commercial manufacturing environments, and has experience with integrated manufacturing and contract manufacturing business models. He has extensive expertise in the areas of deviation - CAPA, change control, GMP auditing, GMP training, and regulatory inspection preparation and management.

Working with large and small companies, Mr. Campbell has successfully developed, remediated and implemented key quality systems. He is a skilled GMP auditor, and has audited multiple API, drug product, packaging, testing, and distribution facilities. He is an experienced GMP trainer, and has developed customized and interactive training presentations for many companies. He has also provided FDA inspection support for several clients, including readiness training, on-site assistance during inspections, and authoring written responses to inspectional observations. Prior to becoming a consultant in 2007, Mr. Campbell worked for Ligand Pharmaceuticals as director of quality systems. Please contact the event manager Marilyn (marilyn.b.turner@nyeventslist.com ) below for: - Multiple participant discounts - Price quotations or visa invitation letters - Payment by alternate channels (PayPal, check, Western Union, wire transfers etc) - Event sponsorships NO REFUNDS ALLOWED ON REGISTRATIONS Service fees included in this listing. ----------------------------------------------------------------- Metricstream Inc- New York Events List http://www.nyeventslist.com http://www.bostoneventslist.com http://www.sfbayeventslist.com ----------------------------------------------------------------- JOA190513CEV